Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

70.10 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 94
Open 70.10
Bid (Size) 69.54 (200)
Ask (Size) 70.44 (100)
Prev. Close 70.10
Today's Range 70.10 - 70.10
52wk Range 54.11 - 93.25
Shares Outstanding 390,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer
From DexCom, Inc.
Via Business Wire
News headline image
3 Nasdaq 100 Stocks Worth Your Attention
The Nasdaq 100 (^NDX) is where investors find some of the most innovative and disruptive companies shaping the future. A select few continue to execute at a high level, growing their market dominance... 
Via StockStory

Performance

YTD
+5.4%
+5.4%
1 Month
+6.8%
+6.8%
3 Month
+3.4%
+3.4%
6 Month
-17.4%
-17.4%
1 Year
-11.7%
-11.7%

More News

Read More
News headline image
The Evolution of a Healthcare Giant: Abbott Laboratories (ABT) 2026 Stock Feature
Via PredictStreet
Topics Economy Lawsuit World Trade
News headline image
2 Healthcare Stocks for Long-Term Investors and 1 We Find Risky
Via StockStory
Topics Stocks
News headline image
2 Growth Stocks to Buy For 2026 and Beyond ↗
Via The Motley Fool
Topics Economy
News headline image
DexCom Inc (NASDAQ:DXCM) Embodies the Growth at a Reasonable Price (GARP) Strategy ↗
Via Chartmill
News headline image
DEXCOM CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds DXCM Investors of the December 26th Deadline for Contacting the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
The $65 Billion Pulse: How Wearable AI and Telemedicine are Redefining the Future of Healthcare
Via MarketMinute
Topics Artificial Intelligence
News headline image
1 Cash-Heavy Stock for Long-Term Investors and 2 We Avoid
Via StockStory
News headline image
DEXCOM CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds DXCM Investors of the December 26th Deadline for Contacting the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
DXCM Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. (DXCM) Investors of Filing Deadline in Class Action Lawsuit
Via TheNewswire.com
Topics Lawsuit
News headline image
DXCM Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. (DXCM) Investors of Filing Deadline in Class Action Lawsuit
Via NewMediaWire
Topics Lawsuit
News headline image
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against DexCom, Inc. (NASDAQ: DXCM)
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
DexCom Inc (NASDAQ:DXCM): A High-Growth Stock Forming a Bullish Technical Setup ↗
Via Chartmill
News headline image
1 Cash-Producing Stock with Impressive Fundamentals and 2 We Ignore
Via StockStory
News headline image
Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
DXCM DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Dexcom, Inc. (DXCM) Securities Fraud Class Action Lawsuit
Via NewMediaWire
Topics Fraud Lawsuit
News headline image
DXCM DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Dexcom, Inc. (DXCM) Securities Fraud Class Action Lawsuit
Via TheNewswire.com
Topics Fraud Lawsuit
News headline image
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against DexCom, Inc. (NASDAQ: DXCM)
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DexCom and CarMax and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
DXCM DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages DexCom, Inc. Investors to Secure Counsel Before Important December 29 Deadline in Securities Class Action – DXCM
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
“Buying the Dip” in 2025: A Strategy Rewarded, But Future Requires Caution and Diversification
Via MarketMinute
Topics Artificial Intelligence Economy

Frequently Asked Questions

Is DexCom, Inc. - Common Stock publicly traded?
Yes, DexCom, Inc. - Common Stock is publicly traded.
What exchange does DexCom, Inc. - Common Stock trade on?
DexCom, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for DexCom, Inc. - Common Stock?
The ticker symbol for DexCom, Inc. - Common Stock is DXCM on the Nasdaq Stock Market
What is the current price of DexCom, Inc. - Common Stock?
The current price of DexCom, Inc. - Common Stock is 70.10
When was DexCom, Inc. - Common Stock last traded?
The last trade of DexCom, Inc. - Common Stock was at 01/07/26 04:00 PM ET
What is the market capitalization of DexCom, Inc. - Common Stock?
The market capitalization of DexCom, Inc. - Common Stock is 27.34B
How many shares of DexCom, Inc. - Common Stock are outstanding?
DexCom, Inc. - Common Stock has 27B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.